Gf Fund Management Co. Ltd. Biogen Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 34,242 shares of BIIB stock, worth $4.82 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
34,242Holding current value
$4.82 Million% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
997Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.36 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.26 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.04 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.04 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$693 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.3B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...